iShares Biotechnology ETF
IBB
IBB
583 hedge funds and large institutions have $6.44B invested in iShares Biotechnology ETF in 2017 Q3 according to their latest regulatory filings, with 78 funds opening new positions, 212 increasing their positions, 173 reducing their positions, and 52 closing their positions.
Holders
583
Holders Change
+22
Holders Change %
+3.92%
% of All Funds
14.56%
Holding in Top 10
30
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-9.09%
% of All Funds
0.75%
New
78
Increased
212
Reduced
173
Closed
52
Calls
$810M
Puts
$1.04B
Net Calls
-$233M
Net Calls Change
-$55.9M
Top Buyers
1 |
1
Bank of America
Charlotte,
North Carolina
|
$1.51B |
2 |
CI
2
Clal Insurance
Tel-Aviv,
Israel
|
$212M |
3 |
N
3
Natixis
Paris,
France
|
$117M |
4 |
4
Goldman Sachs
New York
|
$446M |
5 |
5
Jane Street
New York
|
$68.3M |